Perspective Therapeutics, Inc. revenue for the last year amounted to 1.43 M USD, the most of which — 1.43 M USD — came from its highest performing source at the moment, Precision-targeted Alpha Therapies. The greatest contribution to the revenue figure was made by United States — last year it brought Perspective Therapeutics, Inc. 1.43 M USD, and the year before that — 10.79 M USD.